Smruthi Organics Peer Comparison

In the Pharmaceuticals & Drugs sector, Smruthi Organics Ltd. significantly underperforms compared to its peers, showing zero growth and profitability metrics. In contrast, companies like Sun Pharmaceutical and Cipla demonstrate strong growth, solid profitability, and attractive valuations, making them sector leaders. Smruthi's financials indicate it is a potential value trap, requiring careful consideration by investors.

• • Smruthi Organics Ltd. shows no revenue growth and zero profitability metrics.
• • Sun Pharmaceutical Industries and Cipla lead in profitability and growth with high ROE and EPS.
• • Dr. Reddy's Laboratories and Mankind Pharma are strong performers with robust revenue growth and efficient operations.

• • Sun Pharmaceutical Industries Ltd.: Highest revenue growth (YoY: 8.42%) and strong profitability (ROE: 16.13%, EPS: 45.55).
• • Cipla Ltd.: Strong growth (YoY: 13.28%) with solid profitability metrics (ROE: 16.63%, PE: 23.73).
• • Dr. Reddy's Laboratories Ltd.: Consistent growth (YoY: 16.54%) with attractive valuation (PE: 15.50) and high ROE (21.76).